Mucinex d and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mucinex d (guaifenesin; pseudoephedrine hydrochloride) and Pataday (olopatadine hydrochloride). Common drug interactions include urinary tract infection among females.

The phase IV clinical study analyzes what interactions people have when they take Mucinex d and Pataday. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Mucinex d?

Mucinex d has active ingredients of guaifenesin; pseudoephedrine hydrochloride. It is often used in sinus congestion. eHealthMe is studying from 1,926 Mucinex d users. Check the latest studies of Mucinex d.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.



On Jul, 17, 2026

16 people who take Mucinex d and Pataday together, and have interactions are studied.

Mucinex d and Pataday drug interactions.

What are the common drug interactions of Mucinex D and Pataday, by gender? *:

female:

  1. Urinary tract infection
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  4. Headache (pain in head)
  5. Seasonal allergy (allergic condition due to certain season)
  6. Ageusia (loss of taste functions of the tongue)
  7. Bladder discomfort
  8. Confusional state
  9. Cough
  10. Decreased appetite

male:

n/a

What are the common drug interactions of Mucinex D and Pataday, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cough
  2. Decreased appetite
  3. Diarrhoea
  4. Intestinal polyp (small growths in the bowel with the potential for further growth)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Rash
  7. Respiratory tract congestion (blockage on respiratory system)
  8. Rhinorrhoea (watery mucus discharge from the nose)
  9. Vomiting
  10. Weight decreased

60+:

  1. Asthma
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Fatigue (feeling of tiredness)
  4. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Urinary tract infection
  7. Seasonal allergy (allergic condition due to certain season)
  8. Multiple allergies (allergy to multiple agents)

What are the existing conditions these people have? *

  1. Secondary Immunodeficiency (lack of immunity due to some disease): 4 people, 25.00%
  2. Immunodeficiency Common Variable: 4 people, 25.00%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 12.50%
  4. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 6.25%
  5. Stress And Anxiety: 1 person, 6.25%
  6. Primary Immunodeficiency Syndrome: 1 person, 6.25%
  7. Pain: 1 person, 6.25%
  8. Nausea (feeling of having an urge to vomit): 1 person, 6.25%
  9. Lung Carcinoma Cell Type Unspecified Stage 0 (the lung cancer has not spread beyond the inner lining of the lung): 1 person, 6.25%
  10. Lung Cancer - Non-Small Cell (lung cancer): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Mucinex d and Pataday?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mucinex d and Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mucinex d:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mucinex d and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pataday and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin; pseudoephedrine hydrochloride and olopatadine hydrochloride (the active ingredients of Mucinex d and Pataday, respectively), and Mucinex d and Pataday (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: